Viewing Study NCT02807961


Ignite Creation Date: 2025-12-24 @ 1:04 PM
Ignite Modification Date: 2025-12-29 @ 3:37 AM
Study NCT ID: NCT02807961
Status: TERMINATED
Last Update Posted: 2019-10-22
First Post: 2016-06-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Tolerability, Pharmacokinetics of ELX-02 in Healthy Adult Volunteers
Sponsor: Eloxx Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module